Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 536-541

  Bauer, L ^a   Bohle, B ^a   Jahn Schmid, B ^a   Wiedermann, U ^a   Daser, A ^b   Renz, H ^b   Kraft, D ^a   Ebner, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Immunotherapy; T cell epitope; Tolerance; Type I allergy

Indexed keywords

IMMUNOGLOBULIN E; POLLEN ANTIGEN;

ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TEST; T LYMPHOCYTE;

EID: 0031054483     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-953.x     Document Type: Article

References (37)

1. Noon J. Prophylactic inoculation for hay fever. Lancet 1911; 1:1572-3.
2. Malling HL, Weeke B. Position paper: immunotherapy. Allergy 1993; 14 (Suppl.):9-35.
3. Committee on safety on medicines. CSM update: desensitising vaccines. BMJ 1986; 293:948.
4. Rocklin RE. Immune mechanisms in allergen-specific immunotherapy. Clin Immunol Immunopathol 1989; 53:S119-31.
5. Norman PS. Modern concepts in immunotherapy. Curr Opin Immunol 1993; 5:968-73.
6. Bradley BL, Azzawi M, Jacobson M et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages, in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88:661-74.
7. + T cells from allergic individuals. J Exp Med 1993; 178:2123-30.
8. Varney V, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, Kay AB, Durham SR. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous responses. J Clin Invest 1993; 92:644-51.
9. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Müller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995; 154:4187-94.
10. O'Hehir RE, Yssel H, Verma S, de Vries JE, Spits H, Lamb JR. Clonal analysis of differential lymphokine secretion in peptide and super-antigen induced anergy. Int Immunol 1991; 3:819-26.
11. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int Immunol 1993; 5:1159-65.
12. Gaur A, Wiers B, Liu A, Rothbard J, Fathman CG. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992; 258:1491-4.
13. Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. Induction of tolerance in influenza-virus immune T lymphocyte clones with synthetic peptides of influenza haemagglutinin. J Exp Med 1983; 157:1434-47.
14. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169:1042-4.
15. Linsley PS, Clark EA, Ledbetter JA. T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990; 87:5031-5.
16. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174:561-9.
17. Freedman AS, Freeman G, Horowitz JC, Daley J, Nadler LM. B7, a B cell restricted antigen that identifies preactivated B cells. J Immunol 1987; 139:3260-7.
18. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo Jr VA, Lombard A, Gray GS, Nadler LM. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262:909-11.
19. Briner TJ, Kuo MC, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 1993; 90:7608-12.
20. Hoyne GF, O'Hehir R, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993; 178:1783-8.
21. Ebner C, Szepfalusi Z, Ferreira F et al. Identification of multiple T cell epitopes on Bet v 1, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993; 150:1047-54.
22. Yssel H, Johnson KE, Schneider PV, Wideman A, Terr A, Kastelein R, De Vries DE. T cell activation-inducing epitopes of the house dust mite allergen Der p 1. J Immunol 1992; 148:738-45.
23. Dhillon M, Roberts MC, Nunn T, Kuo M. Mapping human T cell epitopes on phospholipase A2: the major bee-venom allergen. J Allergy Clin Immunol 1992; 90:42-51.
24. Van Neerven RJJ, Van't Hof W, Ringrose JH, Jansen HM, Aalberse RC, Wierenga EA, Kapsenberg M. T cell epitopes of house dust mite major allergen Der p 2. J Immunol 1994; 151:2326-35.
25. Van Neerven RJJ, Van de Pol MM, Van Milligen FJ, Jansen HM, Aalberse RC, Kapsenberg M. Characterization of cat dander-specific T lymphocytes from atopic patients. J Immunol 1994; 152:4203-10.
26. Spiegelberg HL, Beck L, Stevenson D, Ishioka GY. Recognition of T cell epitopes and lymphokine secretion by rye-grass allergen Lolium perenne-specific human T cell clones. J Immunol 1994; 152:4706-11.
27. Ebner C, Schenk S, Najafian N et al. T cell clones (TCC) from non-allergic individuals recognize the same epitopes of Bet v 1, the major birch pollen allergen, as TCC from atopic patients. J Immunol 1995; 154:1932-40.
28. Schenk S, Breiteneder H, Susani M et al. T cell epitopes of Ph1 p 1, major allergen of timothy grass (Phleum pratense). Evidence for crossreacting and non-crossreacting T cell epitopes within grass group I allergens. J Allergy Clin Immunol 1995; 96:986-96.
29. Norman PS, Ohman JL, Long AA et al. Follow on study of the first clinical trial with T cell defined peptides from cat allergen Fel d 1. J Allergy Clin Immunol 1995; 95-1: 259 (Abstr.).
30. Breiteneder H, Pettenburger K, Bito A, Kraft D, Rumpold H, Scheiner O, Breitenbach M. The gene coding for the major birch pollen allergen, rBet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989; 8:1935-8.
31. Ferreira F, Hoffmann-Sommergruber K, Breiteneder H et al. Purification and characterization of recombinant Bet v 1, the major birch pollen allergen. Immunological equivalence to natural Bet v 1. J Biol Chem 1993; 268:19574-80.
32. Saloga J, Renz H, Lack G, Bradley KL, Greenstein JL, Larsen G, Gelfand EW. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. J Clin Invest 1993; 91:133-40.
33. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci USA 1987; 84:5409-13.
34. Burstein HJ, Shea CM, Abbas AK. Aqueous antigens induce in vivo tolerance selectively in IL-2 and IFN-γ (Th1) cells. J Immunol 1992; 148:3687-91.
35. O'Hehir RE, Garman RD, Greenstein JL, Lamb JR. The specificity and regulation of T-cell responsiveness to allergens. Annu Rev Immunol 1991; 9:67-95.
36. Kuna P, Alam R, Kumanska B et al. The effect of preseasonal immunotherapy on the production of histamin-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study. J Allergy Clin Immunol 1989; 83:816-24.
37. O'Hehir RE, Hoyne GF, Thomas WR, Lamb JR. House dust mite allergy: from T cell epitopes to immunotherapy. Eur J Clin Invest 1993; 23:763-72.